Andrew Godwin, PhD, deputy director of the University of Kansas Cancer Center, will lead the project, which will support four core facilities: quantitative omics, biobanking and biomarker validation, biomedical engineering and patient and community engagement.
“Precision medicine has the potential to change the landscape of how we provide care,” UKMC Executive Vice Chancellor Robert Simari, MD, said in a news release. “Receiving a grant of this size is remarkable and will enable our researchers to develop tailored treatments for all types of diseases.”
More articles on health IT:
AI may help detect ICU patient mobility, study shows
Some tech employees reportedly taking diabetes drug to improve health
JPMorgan Chase awards AI research grants to universities, PhD students